World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 40

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8654)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series, Tables (1-2) series.

Item

Count

PDF

177

WORD

HTML

4485

Figures (1-9)

463

Tables (1-2)

476

Sum=5656

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

312

Download

1097

Sum=1409

Publishing Process of This Article

Item

Count

Browse

286

Download

1040

Sum=1326

Oct 28, 2023 (publication date) through Jul 2, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Li YN, Xie B, Zhang Y, He MH, Xing Y, Mu DM, Wang H, Guo R. Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023). World J Gastroenterol 2023; 29(40): 5593-5617 [PMID: 37970478 DOI: 10.3748/wjg.v29.i40.5593]
URL:	https://www.wjgnet.com/1007-9327/full/v29/i40/5593.htm

Number	Citing Articles
1	Sanjeevram Dhandapani, Abdus Samad, Ying Liu, Rongbo Wang, Sri Renukadevi Balusamy, Haribalan Perumalsamy, Yeon-Ju Kim. Coprisin/Compound K Conjugated Gold Nanoparticles Induced Cell Death through Apoptosis and Ferroptosis Pathway in Adenocarcinoma Gastric Cells. ACS Omega 2024; 9(24): 25932 doi: 10.1021/acsomega.4c00554
2	Guodong Liang, Yuehan Ma, Ping Deng, Shufeng Li, Chunyan He, Haihang He, Hairui Liu, Yunda Fan, Ze Li. Role of cell-based therapies in digestive disorders: Obstacles and opportunities. Regenerative Therapy 2025; 29: 1 doi: 10.1016/j.reth.2025.02.009
3	John K Triantafillidis, Manousos M Konstadoulakis, Apostolos E Papalois. Immunotherapy of gastric cancer: Present status and future perspectives. World Journal of Gastroenterology 2024; 30(8): 779-793 doi: 10.3748/wjg.v30.i8.779 Abstract(680) \| Core Tip(682) \| Full Article(HTML)(4333) \| Full Article with Cover (PDF)-1302K(140) \| Full Article (Word)-310K(14) \| Audio-6828K(3) \| Peer-Review Report-266K(94) \| Answering Reviewers-133K(104) \| Full Article (PDF)-940K(265) \| Full Article (XML)-220K(97) \| Times Cited (8) \| Total Visits (8958) \| Open
4	Kavita A Iyer, Rumiana Tenchov, Julian M Ivanov, Qiongqiong Angela Zhou. Emerging Concepts in Immuno-Oncology: Insights from Natural Language Processing-Driven Co-Occurrence Analysis. ACS Omega 2025; doi: 10.1021/acsomega.5c00693
5	Grigorios Christodoulidis, Konstantinos Eleftherios Koumarelas, Marina Nektaria Kouliou. Revolutionizing gastric cancer treatment: The potential of immunotherapy. World Journal of Gastroenterology 2024; 30(4): 286-289 doi: 10.3748/wjg.v30.i4.286 Abstract(681) \| Core Tip(613) \| Full Article(HTML)(4184) \| Full Article with Cover (PDF)-783K(202) \| Full Article (Word)-111K(18) \| Audio-1591K(10) \| Peer-Review Report-226K(78) \| Answering Reviewers-85K(82) \| Full Article (PDF)-349K(215) \| Full Article (XML)-43K(90) \| Times Cited (15) \| Total Visits (8130) \| Open
6	Yasin Kutlu, Shute Ailia Dae, Feride Yilmaz, Dilek Erdem, Mehmet Ali Nahit Sendur, Sinem Akbas, Elif Senocak Tasci, Onur Bas, Faysal Dane, Abdullah Sakin, Ali Osman Kaya, Musa Baris Aykan, Yakup Ergun, Sedat Biter, Umut Disel, Mustafa Korkmaz, Fatih Selcukbiricik, Fatih Kose, Omer Fatih Olmez, Ahmet Bilici, Gokhan Demir, Suayib Yalcin. Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study. Cancers 2024; 16(12): 2251 doi: 10.3390/cancers16122251
7	Margherita Ratti, Elena Orlandi, Ilaria Toscani, Stefano Vecchia, Elisa Anselmi, Jens Claus Hahne, Michele Ghidini, Chiara Citterio. Emerging Therapeutic Targets and Future Directions in Advanced Gastric Cancer: A Comprehensive Review. Cancers 2024; 16(15): 2692 doi: 10.3390/cancers16152692
8	Qian-Cheng Du, Xin-Yu Wang, Hua Yu. Gastric cancer immunotherapy: A scientometric and clinical trial review. World Journal of Gastroenterology 2024; 30(2): 196-198 doi: 10.3748/wjg.v30.i2.196 Abstract(580) \| Core Tip(646) \| Full Article(HTML)(2220) \| Full Article with Cover (PDF)-1515K(121) \| Full Article (Word)-102K(22) \| Audio-703K(6) \| Peer-Review Report-312K(94) \| Answering Reviewers-94K(82) \| Full Article (PDF)-317K(180) \| Full Article (XML)-15K(91) \| Times Cited (1) \| Total Visits (5273) \| Open
9	Shi-Yan Yan, Jian-Gao Fan. Application of immune checkpoint inhibitors and microsatellite instability in gastric cancer. World Journal of Gastroenterology 2024; 30(21): 2734-2739 doi: 10.3748/wjg.v30.i21.2734 Abstract(502) \| Core Tip(548) \| Full Article(HTML)(2453) \| Full Article with Cover (PDF)-1733K(121) \| Audio-1342K(5) \| Peer-Review Report-217K(61) \| Answering Reviewers-26K(69) \| Full Article (PDF)-387K(138) \| Full Article (XML)-109K(65) \| Times Cited (3) \| Total Visits (4629) \| Open